VFA
ICPT

Valeo Financial Advisors’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Valeo Financial Advisors’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-2,475
Closed -$119K – 2227
2020
Q2 		$119K Hold
2,475
– – 0.01% 451
2020
Q1 		$171K Sell
2,475
-1,075
-30% -$96.6K 0.02% 318
2019
Q4 		$440K Buy
3,550
+3,450
+3,450% +$309K 0.04% 206
2019
Q3 		$7K Hold
100
– – ﹤0.01% 1135
2019
Q2 		$8K Hold
100
– – ﹤0.01% 1101
2019
Q1 		$11K Hold
100
– – ﹤0.01% 949
2018
Q4 		$10K Sell
100
-10
-9% -$1.04K ﹤0.01% 896
2018
Q3 		$10K Buy
+110
New +$11.6K ﹤0.01% 980

Other funds holding ICPT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

Valeo Financial Advisors's ICPT Position: Q3 2020 in Review

Valeo Financial Advisors sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q3 2020, closing a stake of 2,475 shares — an estimated $119K sold.

Valeo Financial Advisors first reported a position in ICPT in Q3 2018 and held it in 8 quarters. The position peaked at $440K in Q4 2019. 177 funds tracked by Wall St. Rank hold ICPT as of Q3 2020.

  • Valeo Financial Advisors reported no remaining Intercept Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
  • Valeo Financial Advisors sold 2,475 Intercept Pharmaceuticals, Inc. shares in Q3 2020, an estimated $119K.
  • Valeo Financial Advisors first reported a position in Intercept Pharmaceuticals, Inc. in Q3 2018 and held it in 8 quarters.
  • Valeo Financial Advisors's Intercept Pharmaceuticals, Inc. position peaked at $440K in Q4 2019.
  • 177 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q3 2020.

Based on Valeo Financial Advisors's 13F filing for Q3 2020, filed 28 Oct 2020.